Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications
Cannabis Law Report
NOVEMBER 24, 2021
upcoming seminars). Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Tilray is identified in the article as “a Canadian company that sells cannabidiol (CBD) and tetrahydrocannabinol (THC) extracts to approved Australian patients for up to $420 per 25?mL Full size image. Visual Studies.
52 
Let's personalize your content